arrow
V

Valeria Maria Pinto

irccs azienda ospedaliera metropolitana policlinico ospedale san martino
H指数:22
被引数:1,858

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal Kidney Function Trajectories and Their Association With Hemoglobin and Transfusion Phenotype in Adults With β-Thalassemia

成人β-地中海贫血患者中肾功能纵向变化轨迹及其与血红蛋白和输血表型的关联

2026-11-130
PRE
EHA Guidelines on the management of children and adults with hemoglobin SC disease

欧洲血液学协会关于血红蛋白SC病患者儿童和成人管理的指南

2026-10-070
OAAI
Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee

输血依赖型地中海贫血造血细胞移植的预处理方案:EBMT实践协调与指南委员会的建议

2026-07-220
PRE
Refined classification and phenotype-driven analysis of PIEZO1 variants in hereditary red cell and iron disorders

对遗传性红细胞和铁代谢紊乱中PIEZO1变异的精化分类及表型驱动的分析

Blood
IF23.1
2026-04-230
OAAI
Narratives unveil knowledge and awareness-related issue, reinforcing patients’ self-identity in sickle cell disease

叙事揭示了与知识和意识相关的问题,强化了镰状细胞病患者的自我认同。

2026-02-190
OAAI
Coinheritance of PIEZO1 variants and multi-locus red blood cell defects account for the symptomatic phenotype in beta-thalassemia carriers

PIEZO1变异和多位点红细胞缺陷的共遗传导致 β 地中海贫血携带者的症状表型

2023-03-174
OA
Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients
2023-03-152
OA
Reply to Hepatocellular carcinoma in thalassemia and other hemoglobinopathies
CANCER
IF5.1
2023-03-140
OAAI
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021
CANCER
IF5.1
2022-11-0212
OAAI
Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy

基于去铁酮的铁螯合疗法治疗的NBIA患者的长期神经放射学和临床评估

2022-08-039
OAAI
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy

多种族镰状细胞患者的输血方法: 来自意大利多中心调查的真实世界实践数据

2022-03-164
OAAI